SpaceX’s record-breaking IPO has created ripples in the ETF world, leading to new types of funds and an ecosystem of products built around mega-IPOs according to TD Securities' Andres Ricon.

CRISPR Therapeutics wins FDA pediatric approval for Casgevy, boosting market potential and pipeline upside despite slow uptake. Click here to read more.

U.S. Markets Will Be Shut on Friday for Independence Day ...

Owner-ops have long expressed fears about ELDs, data manipulation, and foreign influence. New research from NMFTA vindicates ...

"We’re at the point where we can actually cure a large number of patients," the centre's director says.